LQDA PEER ANALYSIS

Liquidia Technologies Inc — metric-by-metric comparison with peers and the industry median

LQDALiquidia Technologies Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

LQDAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	LQDA	ROVI	BHC	ECILC	MRK	GENIL	Ind. Median
P/E	359.07	22.16●	—	—	24.51	46.82	21.35
P/B	73.76	4.33	-0.87●	0.80	2.09	3.47	1.77
EV/EBITDA	148.18	14.69	4.05●	33.84	11.78	14.07	12.18
P/S	27.80	3.94	0.20●	5.03	2.96	1.86	2.08

Financial Health
Metric	LQDA	ROVI	BHC	ECILC	MRK	GENIL	Ind. Median
Current Ratio	2.22	3.66●	1.32	1.73	1.51	1.33	2.22
Debt/Equity	170.2%	17.0%	-1,010.0%●	5.9%	40.5%	41.0%	46.3%
NetDebt/EBITDA	-0.71●	0.09	3.71	-0.10	1.38	1.10	1.24

Profitability
Metric	LQDA	ROVI	BHC	ECILC	MRK	GENIL	Ind. Median
Net Margin	7.7%	17.8%●	-13.5%	-3.6%	12.1%	4.0%	4.0%
ROE	28.2%●	20.9%	—	-0.6%	8.5%	8.7%	6.4%
ROA	7.1%	15.1%●	-4.7%	-0.5%	4.9%	4.8%	3.4%
EBITDA Margin	18.7%	27.0%	60.0%●	14.8%	28.5%	14.3%	18.2%

Growth + Dividend
Metric	LQDA	ROVI	BHC	ECILC	MRK	GENIL	Ind. Median
Rev. Growth	1,936.7%●	-3.4%	-9.9%	-2.3%	-1.7%	16.3%	7.5%
NI Growth	—	-5.9%	—	—	-10.1%	146.6%●	5.0%
Div. Yield	—	1.6%	0.0%	2.6%●	1.5%	0.0%	2.0%
Payout	—	36.3%	0.0%	-365.1%	11.8%	0.0%	0.8%

Valuation
Metric	LQDA	HIMS	LNTH	ALKS	AMRX	KNSA	Ind. Median
P/E	359.07	—	24.24●	60.01	45.49	70.80	21.35
P/B	73.76	19.59	5.58	5.23	-122.56●	8.54	1.77
EV/EBITDA	148.18	303.51	14.58	37.03	12.88●	43.78	12.18
P/S	27.80	3.69	4.37	5.87	1.83●	6.86	2.08

Financial Health
Metric	LQDA	HIMS	LNTH	ALKS	AMRX	KNSA	Ind. Median
Current Ratio	2.22	1.69	2.83	2.27	2.47	3.79●	2.22
Debt/Equity	170.2%	253.7%	51.6%	90.3%	-5,938.0%●	1.5%	46.3%
NetDebt/EBITDA	-0.71	12.68	0.27	3.87	3.99	-4.26●	1.24

Profitability
Metric	LQDA	HIMS	LNTH	ALKS	AMRX	KNSA	Ind. Median
Net Margin	7.7%	-0.6%	18.0%●	9.8%	4.0%	9.7%	4.0%
ROE	28.2%●	-2.7%	23.5%	9.4%	—	13.7%	6.4%
ROA	7.1%	-0.8%	12.7%●	4.8%	3.5%	10.3%	3.4%
EBITDA Margin	18.7%	1.3%	30.6%●	17.7%	20.6%	14.3%	18.2%

Growth + Dividend
Metric	LQDA	HIMS	LNTH	ALKS	AMRX	KNSA	Ind. Median
Rev. Growth	1,936.7%●	32.8%	0.6%	3.2%	7.6%	56.7%	7.5%
NI Growth	—	—	9.7%●	-56.7%	—	—	5.0%
Div. Yield	—	—	—	—	—	—	2.0%
Payout	—	—	—	—	—	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on LQDA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.